A side effect of any drug can be defined as the unwanted or undesired effect produced by the drug. The side effect can be major or in few medications minor that can be ignored. Side effects not only vary from drug to drug, but it also depends on the dose of the drug, the individual sensitivity of the person, brand or company which manufactures it. If side effects overweigh the actual effect of the medicine, it may be difficult to convince the patient to take the drug. Few patients get specific side effects to specific drugs; in that case, a doctor replaces the drug with another. If you feel any side effect and it troubles you, do not forget to share with your healthcare practitioner.
The incidence of adverse reactions associated with each component of the formulation, Loratadine (Tadinar-C) and Ambroxol (Tadinar-C) is comparable to placebo. A recommended daily dose LARITOL
EX tablets no clinically significant sedative effects.
The most commonly reported adverse effects include gastrointestinal disorders such as nausea, gastritis, constipation and diarrhea, dry mouth and dryness of the airways, increased salivation and nasal discharge, dysuria, fatigue, headache, drowsiness, dry mouth and allergy symptoms such as rashes.
On rare occasions during the marketing of Loratadine (Tadinar-C) have been reported cases of alopecia, anaphylaxis, hepatic failure.
Contraindication can be described as a special circumstance or a disease or a condition wherein you are not supposed to use the drug or undergo particular treatment as it can harm the patient; at times, it can be dangerous and life threatening as well. When a procedure should not be combined with other procedure or when a medicine cannot be taken with another medicine, it is called Relative contraindication. Contraindications should be taken seriously as they are based on the relative clinical experience of health care providers or from proven research findings.
Loratadine (Tadinar-C), Ambroxol (Tadinar-C) Tablets is contraindicated in patients with hypersensitivity or idiosyncrasy to its components, peptic ulcer, children under 6 years.
DailyMed. "LORATADINE; PSEUDOEPHEDRINE SULFATE: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
DTP/NCI. "loratadine: The NCI Development Therapeutics Program (DTP) provides services and resources to the academic and private-sector research communities worldwide to facilitate the discovery and development of new cancer therapeutic agents.". https://dtp.cancer.gov/dtpstandard/s... (accessed September 17, 2018).
European Chemicals Agency - ECHA. "Ambroxol: The information provided here is aggregated from the "Notified classification and labelling" from ECHA's C&L Inventory. ". https://echa.europa.eu/information-o... (accessed September 17, 2018).
The results of a survey conducted on ndrugs.com for Tadinar-C are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Tadinar-C. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.
Consumer reported side effects
No survey data has been collected yet
There are no reviews yet. Be the first to write one!